PTK2 and hepatocellular carcinoma: Our results indicated that PPP treatments of HCC cells significantly decreased PSPC1-induced cell migration either ectopic or endogenous expression of PSPC1 (Figure 4F–H) as well as FAK/Src and AKT kinase activities in a dose-dependent manner (Figure 4I–K).